Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma

International Journal of Clinical Oncology

Volumn 18, Issue 1, 2013, Pages 154-163

  Kiyosue, Takahiro ^a   Kawano, Shintaro ^a   Matsubara, Ryota ^a   Goto, Yuichi ^a   Hirano, Mitsuhiro ^a   Jinno, Teppei ^a   Toyoshima, Takeshi ^a   Kitamura, Ryoji ^a   Oobu, Kazunari ^a   Nakamura, Seiji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cancer stem cells (CSCs); Immunohistochemistry; Oral leukoplakia (OL); Oral squamous cell carcinoma (OSCC); p75 neurotrophin receptor (p75NTR)

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 5; KI 67 ANTIGEN; NEUROTROPHIN RECEPTOR P75; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CELL STRUCTURE; CHILD; ENZYME ACTIVITY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NERVE TISSUE PROTEINS; PROGNOSIS; RECEPTORS, NERVE GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84874115103     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0358-4     Document Type: Article

References (45)

1. Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156
2. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108
3. Breakhuis BJM, Brakenhoff RH, Leemans CR (2005) Second field tumors: a new opportunity for cancer prevention? Oncologist 10:493-500
4. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730-737
5. Al-Haji M, Wicha MS, Benito-Herandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988
6. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396-401
7. Hemmati HD, Nakano I, Lazareff JA et al (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100:15178-15183
8. Ma S, Chan KW, Hu L et al (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132:2542-2556
9. Zen Y, Fujii T, Yoshikawa S et al (2007) Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol 170:1750-1762
10. Singh SK, Clarke ID, Tearasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828
11. Liu S, Dontsu G, Mantle ID et al (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063-6071
12. Seo DC, Sung JM, Cho HJ et al (2007) Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer 6:75
13. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115
14. Li C, Heidt DG, Dalerba P et al (2007) Identification of pancreatic cancer stem cells. Cancer Res 67:1030-1037
15. Mitsutake N, Iwao A, Nagai K et al (2007) Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 148:1797-1803
16. Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistence by preferential activation of the DNA damage response. Nature 444:756-760
17. + cancer stem cells in glioblastoma. Mol Cancer 5:67
18. Prince ME, Sivanandan R, Kaczorowski A et al (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104:973-978
19. + cancer stem-like cells in squamous cell carcinoma of the head and neck. Head Neck (in press)
20. Zhang P, Zhang Y, Mao L et al (2009) Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer lett 277:227-234
21. Harper LJ, Piper K, Common J et al (2007) Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J Oral Pathol Med 36:594-603
22. Dean M, Fojo T, Bates S (2005) Tumor stem cells and drug resistance. Nat Rev Cancer 5:275-284
23. NTR characterizes human esophageal keratinocyte stem cells in vitro. Oncogene 22:4017-4026
24. Nakamura T, Endo K, Kinoshita S (2007) Identification of human oral keratinocyte stem/progenitor cells by neurotrophin receptor p75 and the role of neurotrophin/p75 signaling. Stem cells 25:628-638
25. Rodriguez-Tebar A, Dechant G, Gotz R et al (1992) Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor. EMBO J 11:917-922
26. Wang X, Bauer JH, Li Y et al (2001) Characterization of a p75(NTR) apoptotic signaling pathway using a novel cellular model. J Biol Chem 276:33812-33820
27. Krygier S, Djakiew D (2002) p75 suppresses growth and NGF mediated metastasis of human prostate cancer cells. Int J Cancer 98:1-7
28. Khwaja F, Djakiew D (2003) Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor. Mol Carcinog 36:153-160
29. Pflug BR, Onoda M, Lynch JH et al (1992) Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 52:5403-5406
30. Gale N, Pilch BZ, Sindramsky D et al (2005) World Health Organization classification of tumors. Pathology and genetics of head and neck tumors. Iarc Press, Lyon, pp 177-179
31. Sobin LH, Witte Sobin LH, Wittekind Ch (eds) (2002) TNM classification of malignant tumors. Wiley-Liss, Inc., New York
32. Yamamoto E, Miyakawa A, Kohama G et al (1984) Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg 6:938-947
33. Lehrer MS, Sun TT, Lavker RM (1998) Strategies of epithelial repair: modulation of stem cell and transit amplifying cell proliferation. J Cell Sci 111:2867-2875
34. Morris RJ, Potten CS (1994) Slowly cycling (label-retaining) epidermal cells behave like clonogenic stem cells in vitro. Cell Prolif 27:279-289
35. Takeda T, Sugihara K, Hirayama Y et al (2006) Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias. J Oral Pathol Med 35:369-375
36. Okumura T, Tsunoda S, Mori Y et al (2006) The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma. Clin Cancer Res 12:5096-5103
37. NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma. Histopahology 53:62-67
38. Tsunoda S, Okumura T, Ito T et al (2006) Significance of nerve growth factor overexpression and its autocrine loop in oesophageal squamous cell carcinoma. Br J cancer 95:322-330
39. Dang C, Zhang Y, Ma Q et al (2006) Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer. J Gastroenterol Hepatol 21:850-858
40. Roux PP, Barker PA (2002) Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 67:203-233
41. Barker P, Shooter E (1994) Disruption of NGF binding to the low affinity neurotrophin receptor p75NTR reduces NGF binding to TrkA on PC12 cells. Neuron 13:203-215
42. Lee KF, Bachman K, Landis S et al (1994) Dependence on p75 for innervation of some sympathetic targets. Science 263:1447-1449
43. Van der Zee CE, Ross GM, Riopelle RJ et al (1996) Survival of cholinergic forebrain neurons in the developing p75 (NGFR) deficient mice. Science 274:1729-1732
44. Dolle L, Adriaenssens E, EI-Yazidi-Belkoura I et al (2004) Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets 4:463-470
45. Descamps S, Toillon RA, Adriaenssens E et al (2001) Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem 276:17864-17870